Vaccines Related News
Longer interval between Pfizer vaccine doses boosts antibody protection
A longer dosing schedule for the Pfizer COVID-19 vaccine triggered the most effective immune response, new research has found.
A new and extensive pre-print study...
Childhood vaccination rates fall globally during COVID-19 pandemic
The COVID-19 pandemic has resulted in a huge global decline in the uptake of childhood vaccinations, new data has revealed.
Official data from WHO and...
Vaccine cold chain specialists B Medical Systems announce new partnership
Global leaders of vaccine cold chain technology, B Medical Systems, have revealed that they will be collaborating with India’s 1mg, a leading digital consumer...
Modifying the immune system could enhance vaccine efficacy
Vaccine efficacy could be enhanced using new insights about the immune system, researchers say.
Immunologists at St. Jude Children's Research Hospital have discovered a biological...
B Medical Systems provides cold chain storage for Sputnik V vaccine rollout
Vaccine cold chain expert B Medical Systems has partnered with Dr. Reddy’s in the pan India rollout of the Sputnik V vaccines.
As part of...
CoronaVac COVID-19 vaccine safe for children as young as three
A clinical trial has proven that the CoronaVac COVID-19 vaccine is safe for children and adolescents aged between three to 17.
The CoronaVac vaccine, which...
Defence Therapeutics: Transforming drug delivery and improving treatment
Defence Therapeutics is continuously expanding on its portfolio of solutions to enhance drug delivery and improve treatment outcomes for patients with cancer and infectious...
Understanding COVID-19 and the vaccine cold chain
B Medical Systems discusses the importance of reliable, high quality bio-medical storage and the crucial impact of the vaccine cold chain.
Optimal cold chain infrastructures...
Defence Therapeutics Accutox exhibits potent anti-cancer properties
Defence Therapeutics Inc. has announced a major breakthrough advance in its pre-clinical research program on its AccuTOX molecules as potent anti-cancer agents.
The AccumTM technology...
Clinicians urged to spot Guillain-Barre syndrome after COVID-19 vaccines
Clinicians have urged for vigilance in looking for the rare neurological disorder Guillain-Barre syndrome in individuals following COVID-19 vaccination.
Clinicians in India and England have...
Intellectual property and vaccine equality in a pandemic
Akshaya Kumar, Director of Crisis Advocacy at Human Rights Watch, speaks to us about intellectual property and vaccine inequity.
In October 2020, representatives of India...
Improving communication and collaboration around vaccines
Alison Maassen and Alba Godfrey of EuroHealthNet explain the importance of the IMMUNION project in improving public knowledge and confidence around vaccines.
Vaccines are a...
Towards a cancer revolution with new targeted therapeutics
Defence Therapeutics Inc’s proprietary new platform offers a revolution in drug delivery.
Quebec-based biotechnology developer Defence Therapeutics Inc specialises in antibody-drug conjugates (ADCs), a novel...
Defence therapeutics vaccine against cancer makes progress
Defence Therapeutics has recently reported its first successes in the fight against cancer with a vaccine.
Defence Therapeutics is a Canadian scientific pioneer, uncovering enhanced...
Is vaccine hesitancy in Africa linked to institutional mistrust?
Dr Jean-François Maystadt, Professor of Economics at Université catholique de Louvain and Lancaster University, discusses institutional mistrust and vaccine hesitancy in Africa.
In a report...
Securing COVID-19 vaccine certificates with distributed ledger
Alex Fryer at Zebra Technologies discusses global vaccine certification systems combined with the use of distributed ledger technology to improve data security and prevent...
Study demonstrates long-lasting efficacy of COVID-19 vaccine programme
Researchers carrying out pre-clinical testing of a COVID-19 vaccine programme have discovered a high antibody response, lasting over 18 weeks.
Biotechnology company Defence Therapeutics Inc...
Mild myocarditis reported with COVID-19 mRNA vaccines
Cases of mild myocarditis are being reported in people who have been vaccinated with the COVID-19 mRNA vaccines.
Myocarditis is an inflammation of the heart...
12-week gap for second Pfizer vaccine achieves peak antibody resistance
Delaying the second Pfizer vaccine dose to 12 weeks significantly increases antibody resistance in older people, a new study has found.
Researchers at the University...
COVID-19 pandemic marks a new era for global health policy
Leaders at the G20 summit committed to a series of actions aiming to accelerate the end of the COVID-19 pandemic across the globe, and...